Evaluation of Changes in Mammographic Breast Density Associated With Bazedoxifene Acetate/Conjugated Estrogens, Raloxifene and Placebo in Postmenopausal Women: An Ancillary Study of Protocol 3115A1-303-WW.
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary) ; Raloxifene
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- Sponsors Pfizer; Wyeth
- 24 Mar 2011 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
- 31 Aug 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 31 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.